利什曼病疫苗研究进展
Advanced on research of Leishmania vaccine
出处
《中国寄生虫病防治杂志》
CSCD
2002年第6期380-382,共3页
Chinese Journal of Parasitic Disease Control
参考文献41
-
1Armijos RX, Weigel MM, Aviles H, et al. Field trial of a vaccine against New World cutaneous leishmaniasia in an at-risk child population:safety, immunogenicity, and efficacy during the first 12 months of follow-up[J]. J Infect Dis, 1998,177(5):1352-1357.
-
2Mendonca SC, de Luca PM, Mayrink W, et al. Characterization of human T lymphocyte-mediated immune responses induced by a vaccine against American tegumentary leishmaniasis[J]. Am J Trop Med Hyg, 1995,53(2):195-201.
-
3Convit J, Rondon A, Ulrich M,et al. Immunotherapy versus chemotherapy in localized cutaneous leishmaniasis[J]. Lancet, 1987,1(8530):401-404.
-
4Cabrera M, Blackwell JM, Castes M, et al. Immunotherapy with live BCG plus heat killed Leishmania induces a T helper 1-like response in American cutaneous leishmaniasis patients[J]. Parasite Immunol, 2000,22(2):73-79.
-
5Momeni AZ, Jalayer T, Emamjomeh M, et al. A randomized, double-blind, controlled trial of a killed L. major vaccine plus BCG against zoonotic cutaneous leishmaniasia in Iran[J]. Vaccine, 1999,17(5):466-472.
-
6Sharifi I, FeKri AR, Aflatonian MR, et al. Randomised vaccine trial of single dose of killed L. major plus BCG against anthroponotic cutaneous leishmaniasia in Bam, Iran[J]. Lancet, 1998,351(9115):1540-1543.
-
7Kenney RT, Sacks DL, Sypek JP, et al. Protective immunity using recombinant human IL-12 and alum as adjuvants in a primate model of cutaneous leishmaniasis[J]. J Immunol, 1999,163(8):4481-4488.
-
8Gicheru MM, Olobo JO, Anjili CO, et al. Vervet monkeys vaccinated with killed Leishmania major parasites and interleukin-12 develop a type 1 immune response but are not protected against challenge infection[J]. Infect Immun, 2001,69(1):245-251.
-
9Misra A, Dube A, Srivastava B, et al. Successful vaccination against Leishmania donovani infection in Indian langur using alum-precipitated autoclaved Leishmania major with BCG[J]. Vaccine, 2001,19(25-26):3485-3492.
-
10Satti IN, Osman HY, Daifalla NS, et al. Immunogenicity and safety of autoclaved Leishmania major plus BCG vaccine in healthy Sudanese volunteers[J]. Vaccine, 2001,19(15-16):2100-2106.
-
1齐蔓莉,刘全忠.增强沙眼衣原体DNA疫苗免疫效应的研究进展[J].国外医学（流行病学．传染病学分册）,2005,32(5):305-307.
-
2江丽君.研究者制定开发结核疫苗的详细计划[J].生物制品快讯,2001(7):6-7.
-
3管立人.由内脏利什曼病的病原引起的皮肤利什曼病[J].预防医学情报杂志,1998,14(2):83-85.
-
4张军霞.委内瑞拉马脑炎病毒基因工程减毒活疫苗:动物模型试验[J].国外医学（预防．诊断．治疗用生物制品分册）,2005,28(2):92-92.
-
5Hugh.,WT.AIDS序幕—对感染机遇的认识[J].世界医学杂志,1999,3(10):52-56.
-
6邓长英,栾一禾,房兴胜,余传信,陈建平,万超群.嗜肺军团菌血清10型致军团病爆发流行并分离培养成功[J].武警医学,1994,5(6):315-317.
-
7Modabber F,王捷.抗利什曼病疫苗[J].国外医学（寄生虫病分册）,1997,24(1):14-17.
-
8钟国梁.从一例发热患者骨髓中分离出杜氏利什曼原虫前鞭毛体[J].中华检验医学杂志,2009,32(7):832-833.
-
9管立人,瞿靖琦,柴君杰.中国利什曼病的现状和对开展防治工作的若干建议[J].地方病通报,2000,15(3):49-53. 被引量：46
-
10管立人,许永湘,左新平,王革.新疆克拉玛依皮肤利什曼病传播媒介的研究[J].地方病通报,1996,11(1):38-41. 被引量：8
